Morningstar

Apiject to Open New U.S. Generic Injectable Drug Manufacturing Facility in Apex, North Carolina

APEX, N.C., Jan. 16, 2026 /PRNewswire/ -- Apiject Holdings, Inc. today announced the signing of a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The ...
Becker's Hospital Review

Eli Lilly plans $3.5B injectable manufacturing site in Pennsylvania

Eli Lilly plans to invest more than $3.5 billion in a new injectable medicine and device manufacturing facility in Pennsylvania. The Lehigh Valley site will manufacture next-generation weight-loss ...
MarketWatch

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market

The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...
Pharmaceutical Commerce

Lilly Bolsters GLP-1 Supply Chain, Pledging $3 Billion Manufacturing Expansion in China

A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...
FOX8 Cleveland

Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines

Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates (ADCs) in the United States, enabling customers to complete the entire ...
Morningstar

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market

GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid ...